Trial intelligence / Profile preview

EUROPA study of perindopril in stable coronary artery disease

ISRCTN37166280Phase 3Completed

Sponsor
Servier
Start
Oct 1997
Modality
Small Molecules
01

Overview

Phase 3, randomised trial in coronary arteriosclerosis comparing Perindopril arm with Placebo arm (2 arms). Primary endpoint: Composite endpoint of cardiovascular mortality, non-fatal myocardial infarction and cardiac arrest resuscitation. Started Oct 1997; status: completed.

02

Drugs

perindopril
03

Conditions

coronary arteriosclerosis

Beyond the preview

Go deeper on ISRCTN37166280.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN37166280.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call